ASC Daily Briefing — July 23, 2026

No new items today. See the Standing Compliance Reference for items currently in effect.

Today’s searches surfaced only items already captured on the standing Page or in recent briefings: the CY 2027 OPPS/ASC Proposed Rule (CMS-1850-P, comment deadline August 31, 2026 — proposed 2.4% ASC payment update, ~618 proposed ASC CPL additions, IPO-list Year 2 removals, ASCQR measure changes, botulinum-toxin prior-authorization expansion, and the AO/EMTALA deeming proposal), the CY 2026 OPPS/ASC Final Rule (CMS-1834-FC) in effect, the Conditions for Coverage at 42 CFR Part 416, the HHS Section 504 MDE baseline, the 10-state ASC prior-authorization demonstration, the state CRNA supervision opt-outs (27 states), AAAHC v44/v45, TJC 2026 standards, the five CMS-approved ASC accreditors, the CMS AO-oversight final rule, and the HHS-OIG 2026 Work Plan. No new enforcement actions, accreditation announcements, or Federal Register ASC notices appeared today; ASC Focus surfaced nothing new in the last ~30 days.

Reminder: the CY 2027 Proposed Rule comment deadline (August 31, 2026) is the next actionable date — 39 days out.